AbCellera Biologics Inc. - Common Shares (NQ: ABCL )
3.270
+0.130
(+4.14%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
All News about AbCellera Biologics Inc. - Common Shares
![](https://mms.businesswire.com/media/20230731085828/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
AbCellera Reports Q2 2023 Business Results
August 03, 2023
Via Business Wire
![](/next-assets/images/schema-image-default.png)
Earnings Preview: AbCellera Biologics
August 02, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230724204358/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/12/lucid_group_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/12/dominos_pizza_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://mms.businesswire.com/media/20230705472679/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20230525005760/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](/next-assets/images/schema-image-default.png)
Recap: AbCellera Biologics Q1 Earnings
May 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
4 Analysts Have This to Say About AbCellera Biologics
February 28, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230524005534/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/23/cohbar_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/growthstocks_1600_03.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
![](https://mms.businesswire.com/media/20230502006253/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
AbCellera Reports Q1 2023 Business Results
May 04, 2023
Via Business Wire
![](https://g.foolcdn.com/editorial/images/729205/artificial-intelligence-ai-on-cloud-circuit-board.jpg)
![](https://investorplace.com/wp-content/uploads/2017/12/cheap-1.jpg)
![](https://mms.businesswire.com/media/20230414005467/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
Via Business Wire
![](https://g.foolcdn.com/editorial/images/727512/health-monitoring-getty.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/cheapstocks1600.jpg)
![](https://mms.businesswire.com/media/20230406005772/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20230404006025/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
![](https://mms.businesswire.com/media/20230320005682/en/1743164/5/RQ_Bio_logo.jpg)
![](https://mms.businesswire.com/media/20230306005767/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230222006058/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
![](https://mms.businesswire.com/media/20230217005378/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
AbCellera Reports Full Year 2022 Business Results
February 21, 2023
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free